Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IcBD-01 enema in active ulcerative colitis
NCT06353828Phase 2Active, not recruiting
- Sponsor
- CannaMore Biotechs
- Start
- Mar 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in ulcerative colitis (UC), sponsored by CannaMore Biotechs. Started Mar 2023; status: active, not recruiting.
02
Drugs
cannabidiol
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06353828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06353828.